We are live on ! Find out more
IBRX icon

ImmunityBio
IBRX

131 hedge funds and large institutions have $84.1M invested in ImmunityBio in 2023 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 33 increasing their positions, 30 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

164% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 11

12% more funds holding

Funds holding: 117 → 131 (+14)

10% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 30

4% less call options, than puts

Call options by funds: $4.51M | Put options by funds: $4.7M

1.5% less ownership

Funds ownership: 8.97% → 7.47% (-1.5%)

23% less capital invested

Capital invested by funds: $109M → $84.1M (-$24.6M)

Holders
131
Holders Change
+14
Holders Change %
+11.97%
% of All Funds
2.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
33
Reduced
30
Closed
11
Calls
$4.51M
Puts
$4.7M
Net Calls
-$190K
Net Calls Change
-$2.05M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$8.72M
2
AC
Armistice Capital
New York
+$6.98M
3
BlackRock
BlackRock
New York
+$2.64M
4
CS
Credit Suisse
Switzerland
+$1.04M
5
Group One Trading
Group One Trading
Illinois
+$897K

Top Sellers

1
DFCM
Dark Forest Capital Management
Puerto Rico
-$566K
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$537K
3
Jane Street
Jane Street
New York
-$295K
4
National Bank of Canada
National Bank of Canada
Quebec, Canada
-$193K
5
State Street
State Street
Massachusetts
-$116K
Name Holding Trade Value Shares
Change 		Change in
Stake
LOIM
51
Liberty One Investment Management
Illinois
$80.4K -$6.04K -3,009 -6%
VOYA Investment Management
52
VOYA Investment Management
Georgia
$77.7K +$4.72K +2,352 +5%
Manulife (Manufacturers Life Insurance)
53
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$77.1K -$2.56K -1,277 -3%
Invesco
54
Invesco
Georgia
$76.8K +$1.59K +792 +2%
ProShare Advisors
55
ProShare Advisors
Maryland
$75.4K +$4.18K +2,080 +5%
Barclays
56
Barclays
United Kingdom
$75K -$32.3K -16,096 -27%
Millennium Management
57
Millennium Management
New York
$74.6K +$88.7K +44,161 New
MFG
58
Merit Financial Group
Georgia
$74K +$40.2K +20,000 +84%
UBS Group
59
UBS Group
Switzerland
$67.2K +$141 +70 +0.2%
Wells Fargo
60
Wells Fargo
California
$66.8K -$49K -24,399 -38%
Teacher Retirement System of Texas
61
Teacher Retirement System of Texas
Texas
$63K +$3.39K +1,687 +5%
ASRS
62
Arizona State Retirement System
Arizona
$62.9K +$1.04K +516 +1%
VEA
63
Virtus ETF Advisers
New York
$58.2K -$6.88K -3,427 -9%
New York State Common Retirement Fund
64
New York State Common Retirement Fund
New York
$57.9K +$1.44K +718 +2%
TSS
65
Two Sigma Securities
New York
$57.4K +$68.2K +33,980 New
SG Americas Securities
66
SG Americas Securities
New York
$57K +$67.7K +33,697 New
State Board of Administration of Florida Retirement System
67
State Board of Administration of Florida Retirement System
Florida
$55K +$2.45K +1,220 +4%
Osaic Holdings
68
Osaic Holdings
Arizona
$48.5K +$31.8K +15,827 +123%
SW
69
SteelPeak Wealth
California
$44.3K – – –
BPA
70
Beacon Pointe Advisors
California
$44K +$52.3K +26,042 New
KAS
71
Kestra Advisory Services
Texas
$39.4K -$6.83K -3,400 -13%
VPIM
72
Vanguard Personalized Indexing Management
California
$36.5K +$43.4K +21,606 New
Pictet Asset Management
73
Pictet Asset Management
Switzerland
$36.4K +$43.3K +21,556 New
WWM
74
Western Wealth Management
Colorado
$35.1K – – –
BFS
75
Bard Financial Services
Connecticut
$32.5K – – –
1 2
3
4 5

IBRX Hedge Fund Activity: Q3 2023 in Review

131 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in ImmunityBio (IBRX) for Q3 2023, worth a combined $84.1M — down 23% from $109M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new IBRX positions and 11 closed out — a net gain of 18 holders — while 33 added to existing stakes and 30 trimmed.

The largest buyer was Vanguard Group, adding an estimated $8.72M. The largest seller was Dark Forest Capital Management, exiting entirely with an estimated $566K sold.

  • 131 institutional investors held ImmunityBio (IBRX) as of Q3 2023, up from 117 in Q2 2023.
  • Funds reported $84.1M of ImmunityBio stock for Q3 2023, down 23% quarter-over-quarter.
  • 29 funds opened new ImmunityBio positions in Q3 2023 and 11 closed out, a net change of +18 holders.
  • The largest ImmunityBio buyer in Q3 2023 was Vanguard Group, an estimated $8.72M added.
  • The largest ImmunityBio seller in Q3 2023 was Dark Forest Capital Management, an estimated $566K sold.

Based on aggregated 13F filings for Q3 2023.